Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
AXGN
AXGN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
AXGN News
Axogen Executive Exercises Stock Options, Sells Shares
5d ago
Fool
DAFNA Capital Management Reduces AXGN Holdings
Mar 22 2026
NASDAQ.COM
DAFNA Capital Management Reduces Axogen Holdings
Mar 22 2026
Fool
Axogen Reports Q4 2025 Earnings with Strong Growth and FDA Milestone
Feb 24 2026
seekingalpha
HighMark Wealth Management Increases Axogen Stake to 4.6%
Feb 24 2026
Fool
HighMark Wealth Management Increases Axogen Stake to 4.6% of AUM
Feb 24 2026
NASDAQ.COM
AxoGen Reports Q4 Earnings Miss with Positive Revenue Growth Outlook
Feb 24 2026
seekingalpha
AxoGen Set to Announce Q4 Earnings on February 24
Feb 23 2026
seekingalpha
Latest Rating Changes on Wall Street
Feb 19 2026
CNBC
Wall Street Analysts Adjust Ratings on Key Stocks
Feb 19 2026
Benzinga
Axogen Prices Upsized Public Offering of 4 Million Shares at $31 Each, Raising Approximately $124 Million
Jan 22 2026
Benzinga
Axogen (AXGN) Prices Upsized Offering of 4 Million Shares at $31, Raising Approximately $124 Million
Jan 22 2026
NASDAQ.COM
Axogen (AXGN) Prices Upsized Public Offering of 4M Shares at $31, Expected to Raise $124M
Jan 22 2026
seekingalpha
Axogen (AXGN) Plans $85M Public Offering to Repay Debt
Jan 21 2026
seekingalpha
Axogen CEO Michael D. Dale Sells 25,000 Shares for $750,000
Jan 14 2026
Fool
Axogen to Present at J.P. Morgan 2026 Healthcare Conference
Dec 17 2025
Globenewswire
Show More News
